Environment and Breast Cancer: Science Review
![Search the Mammary Carcinogens Reviews Database](http://sciencereview.silentspring.org/images/title_search_mamm_data.gif)
Originating list
« Place cursor over headings for an explanation of data.
The list(s) or database(s) in which the chemical was identified as showing an
increase in mammary gland tumors. CPDB: Carcinogenic Potency Database, IARC:
International Agency for Research on Chemicals Monographs on the Evaluation of
Carcinogenic Risk of Chemicals to Man summaries, NTP TR: National Toxicology Program
(NTP) Technical Reports, NTP 11ROC: NTP 11th Report on Carcinogens, CCRIS: Chemical
Carcinogenesis Research Information Service.
IARC Monographs, Chemical Carcinogenesis Research Information System
![](structuresNLM/67-20-9.bmp)
Image from the National Library of Medicine
Associated chemicals
Names of closely related chemicals discussed in the "originating list" are
listed here if they were not separately reviewed.
Nitrofurantoin monohydrate 17140-81-7, Nitrofurantoin sodium salt 54-87-5
Major use
We assigned each chemical into one of the following groups based on its major
sources and uses: industrial chemicals, chlorinated solvents, products of combustion,
pesticides, dyes, radiation and drinking water disinfection, pharmaceuticals, hormones, natural
products, and research chemicals.
Pharmaceutical
Widespread exposure
If a chemical is a High Production Volume chemical, added to food, found in air pollution or consumer products, or causes greater than 5000 women to be exposed occupationally, it was judged to cause a likely widespread exposure to women in the United States.
More Likely
Human exposure summary
Information describing pathways of exposure for the general
population was obtained from a variety of sources, including IARC Monographs (9), NTP 11th
ROC (4), NTP Study Reports (3), and Hazardous Substance Database (10). Summaries of
chemical use in consumer products were developed from information found in US EPA's
Source Ranking Database (SRD) (11), the NLM Household Product Database (HPD)(12),
Scorecard (12), and Pesticide Action Network (PAN) Pesticides Database (13). If a chemical
could not be found in these sources, we searched ToxNet (14), PubChem (15), and The Merck
Index (16), and conducted searches by both name and CAS No. using Google.
Used since 1972 in treatment of urinary tract infection (IARC).
![](http://sciencereview.silentspring.org/images/pixelblack.gif)
Mammary gland tumor summary
A summary of findings related to mammary gland tumors, most
often excerpted from IARC Monographs or the NTP 11th ROC, and, in some cases,
supplemented by our evaluation of individual studies and reviews, is available for the priority
chemicals and 67 others.
IARC 1990: When administered orally, female rats demonstrated an increase in the incidence of mammary fibroadenomas. An NTP study of nitrofurantoin did not find mammary gland tumors.
![](http://sciencereview.silentspring.org/images/pixelblack.gif)
IARC classification
Overall evaluation: Group 1: The agent is carcinogenic to humans.
Group 2A: The agent is probably carcinogenic to humans. Group 2B: The agent is
possibly carcinogenic to humans. Group 3: The agent is not classifiable as to
carcinogenicity in humans. Group 4: The agent is probably not carcinogenic to humans.
NA: not evaluated by IARC (9).
3: Not classifiable as to carcinogenicity in humans
Evidence in humans
Strength of the evidence in humans
(summary of epidemiologic evidence) and animals: sufficient, limited, or inadequate. If
IARC has not reviewed the chemical, this field will be labeled "NA".
inadequate
Tumor sites identified in IARC Monographs
If tumors were found in humans, the entry
in this field will be labeled "(human)." Unlabeled terms are from animal studies. Tumor
sites are abbreviated and can be referenced in the key (Table 1). NA: not evaluated by
IARC.
ovaries, lymphatic system, mammary gland
Evidence in animals
Strength of the evidence in humans
(summary of epidemiologic evidence) and animals: sufficient, limited, or inadequate. If
IARC has not reviewed the chemical, this field will be labeled "NA".
limited
![](http://sciencereview.silentspring.org/images/pixelblack.gif)
US EPA cancer classification
The US EPA Weight of Evidence Characterization of the
chemical’s carcinogenic potential is listed: Group A: Carcinogenic to humans; Group B:
Probably carcinogenic to humans. Group C: Possibly carcinogenic to humans. Group D: Not
classifiable as to human carcinogenicity. Group E: Evidence of non-carcinogenicity for
humans. NA: Not evaluated by US EPA (17).
NA
![](http://sciencereview.silentspring.org/images/pixelblack.gif)
The National Toxicology Program Technical
Reports include a determination of the carcinogenicity of the test chemical in each sex and
species tested. Designations prior to 1983 are "positive" or "negative". After 1983, NTP
assigned designations of "clear evidence of carcinogenicity," "some evidence of
carcinogenicity," "equivocal evidence of carcinogenicity," "no evidence of carcinogenicity," or "inadequate study of carcinogenicity." The words "of carcinogenicity” are removed from the
field in this database to conserve space. "NA" indicates no NTP technical report for the
chemical (3).
Female rats
No evidence
No evidence
Female mice
Clear evidence
Clear evidence
Male rats
Some evidence
Some evidence
Male mice
No evidence
No evidence
![](http://sciencereview.silentspring.org/images/pixelblack.gif)
Mutagenicity from CPDB
This summary of evidence from the Carcinogenic Potency
Database is labeled “Yes” if the agent is mutagenic or weakly mutagenic in the Salmonella assay
and “No” if not. NA: Not listed in CPDB. NA-S: Listed in CPDB, but no assessment of
mutagenicity in Salmonella is included (1).
Mutagenic
Mutagenicity from RTECS
This summary of evidence from the Registry of Toxic Effects of
Chemical Substances database (NIOSH 2005) is labeled “Yes” if the agent is listed as mutagenic,
“No” if not. NA: Not listed in RTECS (18).
Mutagenic